DEA and HHS extend virtual prescribing for controlled substances through 2025
Healthcare It News
NOVEMBER 18, 2024
The agencies also said they would continue to develop the final rule governing the virtual prescribing of controlled substances in the post-pandemic era to be consistent with public health and safety and to mitigate drug diversion risks.
Let's personalize your content